Director Wang Wei of Pathology and Director Sun Junzhong of Oncology from Pingshan Central Hospital Visit Shenzhen Cell Valley for Exchange

Recently, Director Wang Wei of the Pathology Department and Director Sun Junzhong of the Oncology Department from Pingshan Central Hospital visited Shenzhen Cell Valley for exchange and discussion. Our Chairman, Shi Yuanyuan; Director of the General Administration Office, Wang Lu; and R&D Scientist, Yang Yiqing, extended a warm welcome to the delegation.

Under the detailed guidance of Director Wang Lu and R&D Scientist Yang Yiqing, the visiting leadership team first gained a deeper understanding of Shenzhen Cell Valley's strategic positioning, founding team, corporate vision, development history, core technological advantages, and four major service platforms.

During the symposium, Chairman Shi Yuanyuan introduced that recently, Shenzhen Cell Valley's core technology team, in collaboration with high-level medical teams from a public tertiary hospital in Shenzhen, published an international first case report on the clinical cure of advanced relapsed/refractory multiple myeloma using Anti-BCMA CAR-T prepared with retroviral vectors in Heliyon, a multidisciplinary JCR Q1 journal under Cell (for details. This case was built upon Shenzhen Cell Valley's core retroviral vector technology, and the clinical-grade cell products produced demonstrated high yield, low cost, excellent transfection efficiency, and robust in vivo expansion. The success of these clinical studies also signifies that Shenzhen Cell Valley's one-stop, full-process service from basic research to clinical translation has gained recognition from physicians.

Director Sun Junzhong highly commended the progress made by Shenzhen Cell Valley in the cell therapy field and provided an introduction to the Oncology Department of Pingshan Central Hospital. Subsequently, the two sides engaged in in-depth discussions on the application of retroviral vectors in oncology and the current challenges facing cell therapy. Both parties agreed that Shenzhen Cell Valley and Pingshan Central Hospital share a high degree of alignment in their philosophies and a common vision. They expressed the hope to accelerate cooperation and bring new hope and treatment options to cancer patients.